(Total Views: 582)
Posted On: 02/09/2021 5:36:00 PM
Post# of 155266
https://www.cytodyn.com/careers/now-hiring
"CytoDyn is a publicly traded late-stage biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. The Company recently filed a BLA for HIV with the FDA and, if approved, commercial sales could commence in early 2021, or sooner. The Company is also rapidly exploring COVID-19 and various cancer indications."
Did I miss something?
"CytoDyn is a publicly traded late-stage biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. The Company recently filed a BLA for HIV with the FDA and, if approved, commercial sales could commence in early 2021, or sooner. The Company is also rapidly exploring COVID-19 and various cancer indications."
Did I miss something?
(0)
(0)
